CBT (Commodity Chemicals) Stock Valuation & Fair Value Quality business at a reasonable price
CBT (Commodity Chemicals) trades at a blended P/E of 13.6, about 6% below its historical normal valuation, with a forward growth estimate of 8.6% and a PEG of 1.58. Analysts' one-year estimates have been hit 45% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is CBT overvalued?
At a blended P/E of 13.6 versus its historical normal P/E of 14.5, CBT trades about 6% below its typical valuation, with a PEG of 1.58 on 8.6% forward growth. tickerseer currently rates it quality business at a reasonable price.
What is CBT's fair value and PEG?
CBT trades at a blended P/E of 13.6 against a historical normal P/E of 14.5, a PEG of 1.58, and a forward growth estimate of 8.6%.
Has tickerseer's rating of CBT changed?
tickerseer's rating has been quality business at a reasonable price since 2026-07-31.
Industry: Commodity Chemicals. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.